Fin d'année 30 Septembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 3.665 | 3.819 | 5.331 | 4.052 | 4.187 | 3.807 | 3.705 | 3.963 |
Return on Equity (%) | 10.517 | 10.77 | 13.914 | 9.722 | 9.591 | 9.056 | 8.939 | 8.732 |
Return on Invested Capital (%) | 12.316 | 12.931 | 10.647 | 9.186 | 8.672 | 7.749 | 7.508 | 7.481 |
Operating Margin (%) | 19.894 | 26.244 | 23.039 | 25.965 | 29.466 | 26.496 | 22.722 | 26.592 |
Net Profit Margin (%) | 10.451 | 14.364 | 19.357 | 17.623 | 21.319 | 19.532 | 18.431 | 20.72 |
Book Value Per Share | 26.168 | 29.862 | 36.303 | 42.061 | 48.14 | 54.188 | 62.104 | 67.671 |
Earnings Per Share | 3.369 | 3.736 | 5.42 | 4.285 | 4.778 | 5.026 | 5.536 | 5.967 |
Cash Per Share | 0.457 | 0.249 | 0.124 | 0.206 | 0.165 | 0.881 | 0.369 | 0.104 |
Working Capital Per Share | -10.647 | -4.465 | -12.908 | -6.296 | -2.472 | -5.072 | -3.967 | -3.144 |
Operating Profit Per Share | 16.789 | 17.287 | 17.504 | 17.119 | 17.177 | 17.934 | 18.007 | 19.016 |
EBIT Per Share | 5.297 | 5.693 | 5.492 | 5.449 | 5.933 | 6.187 | 6.09 | 6.733 |
EBITDA Per Share | 5.297 | 5.693 | 5.492 | 5.449 | 5.933 | 6.187 | 6.09 | 6.733 |
Free Cash Flow Per Share | 12.692 | 13.251 | 17.295 | 17.255 | 18.984 | 18.736 | 21.867 | 23.695 |
Fin d'année 30 Septembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | 0.381 | 0.532 | 0.25 | 0.379 | 0.602 | 0.809 | 0.846 | 0.655 |
Quick Ratio | 0.194 | 0.245 | 0.072 | 0.112 | 0.168 | 0.077 | 0.115 | 0.131 |
Inventory Turnover (Days) | 26.056 | 25.013 | 20.366 | 17.113 | 15.368 | 20.748 | 33.343 | 23.915 |
Actions en circulation | 103,93M | 106,11M | 111,27M | 119,34M | 125,88M | 132,42M | N/A | N/A |
Fin d'année 30 Septembre 2023 | Mar 2022 | Juin 2022 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | 23.071 | N/A | N/A | N/A | 35.995 |
Net Profit Margin (%) | N/A | N/A | N/A | 18.319 | N/A | N/A | N/A | 26.871 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | 1.027 | N/A | N/A | N/A | 1.435 |
Quick Ratio | N/A | N/A | N/A | 0.283 | N/A | N/A | N/A | 0.796 |
Inventory Turnover (Days) | N/A | N/A | N/A | 79.61 | N/A | N/A | N/A | 69.613 |
Capitalisation boursière | 17,67B |
Ratio cours/bénéfice | 19,95 |
Ratio prix/ventes | 4,13 |
Ratio prix/liquidités | 1,15k |
Ratio prix/valeur comptable | 1,63 |
Rendement de dividende | 252,60% |
Actions en circulation | 150,84M |
Volume moyen (1 semaine) | 940,89k |
Volume moyen (1 mois) | 762,61k |
Variation sur 52 semaines | -1,81% |
Plus haut sur 52 semaines | 125,28 |
Plus bas sur 52 semaines | 101,00 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales